ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Yiwen Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4441-3048; OpenAlex author ID A5025681928. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weidong Zhang · 2 shared papers, 2020–2026 · strength 0.42
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123 ↗
- Paper Blocking CTGF-Mediated Tumor-Stroma Interplay in Pancreatic Cancer. DOI 10.1016/j.molmed.2020.08.005 ↗
Xin Luan · 2 shared papers, 2020–2026 · strength 0.42
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123 ↗
- Paper Blocking CTGF-Mediated Tumor-Stroma Interplay in Pancreatic Cancer. DOI 10.1016/j.molmed.2020.08.005 ↗
Shiqun Wang · 1 shared paper, 2026 · strength 0.26
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123 ↗
Jiang‐Jiang Qin · 1 shared paper, 2026 · strength 0.26
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.